Department of Neurosciences and Behavioral Sciences, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
Interventional Neuroradiology Division, Department of Radiology, Hematology and Oncology, Hospital das Clínicas, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
J Stroke Cerebrovasc Dis. 2020 Oct;29(10):105134. doi: 10.1016/j.jstrokecerebrovasdis.2020.105134. Epub 2020 Jul 17.
Mechanical thrombectomy (MT) is the standard of care for acute ischemic stroke (AIS) caused by large vessel occlusion of the anterior circulation within 6 hours of symptoms onset and can be performed with an extended window up to 24 hours in selected patients. Nevertheless, the outcomes of MT with extended window are unknown in developing countries.
Explore the safety and efficacy of MT for AIS performed beyond 6 hours from symptoms onset in Brazil.
We reviewed data from AIS patients treated with MT beyond 6 hours of stroke onset, from 2015 to 2018 in a Brazilian public hospital. Patients had an occlusion of the intracranial internal carotid artery and/or proximal segment of the middle cerebral artery. CT Perfusion mismatch was evaluated using the RAPID® software. We evaluated the modified Rankin scale (mRS) and mortality at 90 days, and rate of symptomatic intracranial hemorrhage (sICH).
Fifty-four patients were included, with a mean age of 65.6 ± 16.1 years, 55.6% were male, and the median NIHSS score at presentation was 17. Successful recanalization (TICI 2b to 3) was obtained in 92.6% of patients and sICH rate was 11.1%. Overall, 34% of the patients had a good outcome (mRS ≤2) at 90 days and the mortality rate was 20.3%.
Our study, the first series of MT for AIS treated with extended window reported in Latin America, shows that MT can be performed with safety and lead to adequate functional outcomes in this context. Further studies should explore the barriers to broad implementation of MT for AIS in Latin America.
机械取栓(MT)是症状发作 6 小时内前循环大血管闭塞引起的急性缺血性脑卒中(AIS)的标准治疗方法,在选定的患者中可以延长至 24 小时的时间窗内进行。然而,在发展中国家,延长时间窗的 MT 治疗效果尚不清楚。
探索在巴西,对症状发作超过 6 小时的 AIS 患者进行 MT 的安全性和有效性。
我们回顾了 2015 年至 2018 年期间,巴西一家公立医院对超过症状发作 6 小时的 AIS 患者进行 MT 治疗的数据。患者颅内颈内动脉和/或大脑中动脉近端有闭塞。采用 RAPID®软件评估 CT 灌注错配。我们评估了改良 Rankin 量表(mRS)和 90 天死亡率,以及症状性颅内出血(sICH)的发生率。
共纳入 54 例患者,平均年龄为 65.6±16.1 岁,55.6%为男性,发病时 NIHSS 评分为 17 分。92.6%的患者获得了成功再通(TICI 2b 至 3),sICH 发生率为 11.1%。总体而言,90 天时 34%的患者(mRS≤2)预后良好,死亡率为 20.3%。
我们的研究是拉丁美洲首例报道的 AIS 延长时间窗 MT 治疗系列研究,结果表明在这种情况下,MT 可以安全进行,并能获得良好的功能结局。进一步的研究应该探讨在拉丁美洲广泛实施 MT 治疗 AIS 的障碍。